Literature DB >> 16341241

Lipid microarrays identify key mediators of autoimmune brain inflammation.

Jennifer L Kanter1, Sirisha Narayana, Peggy P Ho, Ingrid Catz, Kenneth G Warren, Raymond A Sobel, Lawrence Steinman, William H Robinson.   

Abstract

Recent studies suggest that increased T-cell and autoantibody reactivity to lipids may be present in the autoimmune demyelinating disease multiple sclerosis. To perform large-scale multiplex analysis of antibody responses to lipids in multiple sclerosis, we developed microarrays composed of lipids present in the myelin sheath, including ganglioside, sulfatide, cerebroside, sphingomyelin and total brain lipid fractions. Lipid-array analysis showed lipid-specific antibodies against sulfatide, sphingomyelin and oxidized lipids in cerebrospinal fluid (CSF) derived from individuals with multiple sclerosis. Sulfatide-specific antibodies were also detected in SJL/J mice with acute experimental autoimmune encephalomyelitis (EAE). Immunization of mice with sulfatide plus myelin peptide resulted in a more severe disease course of EAE, and administration of sulfatide-specific antibody exacerbated EAE. Thus, autoimmune responses to sulfatide and other lipids are present in individuals with multiple sclerosis and in EAE, and may contribute to the pathogenesis of autoimmune demyelination.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16341241     DOI: 10.1038/nm1344

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  120 in total

1.  Antigen microarrays identify CNS-produced autoantibodies in RRMS.

Authors:  F J Quintana; M F Farez; G Izquierdo; M Lucas; I R Cohen; H L Weiner
Journal:  Neurology       Date:  2012-01-18       Impact factor: 9.910

Review 2.  New tools for classification and monitoring of autoimmune diseases.

Authors:  Holden T Maecker; Tamsin M Lindstrom; William H Robinson; Paul J Utz; Matthew Hale; Scott D Boyd; Shai S Shen-Orr; C Garrison Fathman
Journal:  Nat Rev Rheumatol       Date:  2012-05-31       Impact factor: 20.543

3.  Anoctamin 2 identified as an autoimmune target in multiple sclerosis.

Authors:  Burcu Ayoglu; Nicholas Mitsios; Ingrid Kockum; Mohsen Khademi; Arash Zandian; Ronald Sjöberg; Björn Forsström; Johan Bredenberg; Izaura Lima Bomfim; Erik Holmgren; Hans Grönlund; André Ortlieb Guerreiro-Cacais; Nada Abdelmagid; Mathias Uhlén; Tim Waterboer; Lars Alfredsson; Jan Mulder; Jochen M Schwenk; Tomas Olsson; Peter Nilsson
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-09       Impact factor: 11.205

4.  Glycoproteins as targets of autoantibodies in CNS inflammation: MOG and more.

Authors:  Marie Cathrin Mayer; Edgar Meinl
Journal:  Ther Adv Neurol Disord       Date:  2012-05       Impact factor: 6.570

Review 5.  The gray aspects of white matter disease in multiple sclerosis.

Authors:  Lawrence Steinman
Journal:  Proc Natl Acad Sci U S A       Date:  2009-05-18       Impact factor: 11.205

6.  Enhancing the ability of experimental autoimmune encephalomyelitis to serve as a more rigorous model of multiple sclerosis through refinement of the experimental design.

Authors:  Mitchell R Emerson; Ryan J Gallagher; Janet G Marquis; Steven M LeVine
Journal:  Comp Med       Date:  2009-04       Impact factor: 0.982

Review 7.  Antigen-specific therapy of multiple sclerosis: the long-sought magic bullet.

Authors:  Lawrence Steinman
Journal:  Neurotherapeutics       Date:  2007-10       Impact factor: 7.620

8.  Selective protein recognition in supported lipid bilayer arrays by tailored, dual-mode deep cavitand hosts.

Authors:  Lizeth Perez; Magi Mettry; Samuel S Hinman; Samantha R Byers; Kristy S McKeating; Bethany G Caulkins; Quan Cheng; Richard J Hooley
Journal:  Soft Matter       Date:  2017-05-31       Impact factor: 3.679

Review 9.  Alzheimer's disease as homeostatic responses to age-related myelin breakdown.

Authors:  George Bartzokis
Journal:  Neurobiol Aging       Date:  2009-09-22       Impact factor: 4.673

10.  Microplate-based characterization of protein-phosphoinositide binding interactions using a synthetic biotinylated headgroup analogue.

Authors:  Denghuang Gong; Matthew D Smith; Debasis Manna; Heidi E Bostic; Wonhwa Cho; Michael D Best
Journal:  Bioconjug Chem       Date:  2009-02       Impact factor: 4.774

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.